Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -123601.69% is 18823% below its 5-year average of -653.18%, near the low end of its 5-year range (-123601.69%–27.39%).
1746.95% below its 12-month average of -6692.20%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-123601.69%
OPERATING MARGIN AVG TTM
-6692.20%
OPERATING MARGIN AVG 3Y
-335.79%
OPERATING MARGIN AVG 5Y
-653.18%
OPERATING MARGIN AVG 10Y
-588.96%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1746.95%
CURRENT VS 3Y AVG
-36709.49%
CURRENT VS 5Y AVG
-18823.02%
CURRENT VS 10Y AVG
-20886.42%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Avalo Therapeutics, Inc.
Market Cap
$712.26M
Operating Margin
-123601.69%
TTM Avg
-6692.20%
3Y Avg
-335.79%
5Y Avg
-653.18%
Market Cap
$715.81M
Operating Margin
19.61%
TTM Avg
25.44%
3Y Avg
21.88%
5Y Avg
18.67%
Market Cap
$718.52M
Operating Margin
-21.60%
TTM Avg
-15.14%
3Y Avg
-11.45%
5Y Avg
-3.99%
Market Cap
$709.26M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$705.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$735.04M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$737.40M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$738.93M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6934.80%
5Y Avg
-9894.67%
Market Cap
$690.35M
Operating Margin
-4908.21%
TTM Avg
-3903.83%
3Y Avg
-2635.01%
5Y Avg
-1845.37%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | $712.26M | -123601.69% | -6692.20% | -335.79% | -653.18% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $715.81M | 19.61% | 25.44% | 21.88% | 18.67% |
| Cytek Biosciences, Inc. (CTKB)vs › | $718.52M | -21.60% | -15.14% | -11.45% | -3.99% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $709.26M | 0.00% | 0.00% | 0.00% | 0.00% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $705.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $735.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| Faeth Therapeutics, Inc. (FTH)vs › | $737.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Candel Therapeutics, Inc. (CADL)vs › | $738.93M | 0.00% | 0.00% | -6934.80% | -9894.67% |
| Anteris Technologies Global Corp. (AVR)vs › | $690.35M | -4908.21% | -3903.83% | -2635.01% | -1845.37% |
| Solid Biosciences Inc. (SLDB)vs › | $684.72M | 0.00% | 0.00% | -328.80% | -307.62% |
Gross Margin
100.0%
Operating Margin
-123601.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -33461.02% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -6932.81% |
| 2024-09-30 | -5165.06% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -656.92% |
| 2023-09-30 | -1588.98% |
| 2023-06-30 | -1111.98% |
| 2023-03-31 | -1850.95% |
| 2022-12-31 | -988.28% |
| 2022-09-30 | 27.39% |
| 2022-06-30 | -1145.01% |
| 2022-03-31 | -1777.75% |
| 2021-12-31 | -8202.28% |
| 2021-09-30 | -1219.48% |
| 2021-06-30 | -792.13% |
| 2021-03-31 | -6465.12% |
| 2020-12-31 | -4865.93% |
| 2020-09-30 | -1195.01% |
| 2020-06-30 | -883.03% |
| 2020-03-31 | -1140.61% |
| 2019-12-31 | -6.61% |
| 2019-09-30 | -66.19% |
| 2019-06-30 | -134.31% |
| 2019-03-31 | -129.78% |
| 2018-12-31 | -117.46% |
| 2018-09-30 | -594.59% |
| 2018-06-30 | -119.94% |
| 2018-03-31 | -77.89% |
| 2017-12-31 | -195.07% |
| 2017-09-30 | 87.55% |
| 2017-06-30 | -1124.84% |
| 2017-03-31 | -494.30% |
| 2016-12-31 | -926.37% |
| 2016-09-30 | -1854.85% |
| 2016-06-30 | -536.22% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -20.96% |
| 2012-12-31 | 0.00% |
